TR200003011T2 - Yeni dihidropirimidinler. - Google Patents

Yeni dihidropirimidinler.

Info

Publication number
TR200003011T2
TR200003011T2 TR2000/03011T TR200003011T TR200003011T2 TR 200003011 T2 TR200003011 T2 TR 200003011T2 TR 2000/03011 T TR2000/03011 T TR 2000/03011T TR 200003011 T TR200003011 T TR 200003011T TR 200003011 T2 TR200003011 T2 TR 200003011T2
Authority
TR
Turkey
Prior art keywords
dihydropyrimidines
new
compounds
new dihydropyrimidines
formulas
Prior art date
Application number
TR2000/03011T
Other languages
English (en)
Turkish (tr)
Inventor
Stoltefuss J�Rgen
Goldmann Siegfried
Kramer Thomas
Schlemmer Karl-Heinz
Niew�Hner Ulrich
Paessens Arnold
Graef Erwin
Lottmann Stefan
Deres Kark
Weber Olaf
St�Lting J�Rn
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of TR200003011T2 publication Critical patent/TR200003011T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
TR2000/03011T 1998-04-18 1999-04-07 Yeni dihidropirimidinler. TR200003011T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19817264A DE19817264A1 (de) 1998-04-18 1998-04-18 Neue Dihydropyrimidine

Publications (1)

Publication Number Publication Date
TR200003011T2 true TR200003011T2 (tr) 2001-01-22

Family

ID=7864972

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03011T TR200003011T2 (tr) 1998-04-18 1999-04-07 Yeni dihidropirimidinler.

Country Status (36)

Country Link
US (3) US6696451B1 (en, 2012)
EP (1) EP1080086B1 (en, 2012)
JP (2) JP4590097B2 (en, 2012)
KR (1) KR100636771B1 (en, 2012)
CN (1) CN1159311C (en, 2012)
AR (1) AR018187A1 (en, 2012)
AT (1) ATE223401T1 (en, 2012)
AU (1) AU740318B2 (en, 2012)
BG (1) BG64649B1 (en, 2012)
BR (2) BRPI9917862B8 (en, 2012)
CA (1) CA2328780C (en, 2012)
CO (1) CO5021127A1 (en, 2012)
CU (1) CU23049A3 (en, 2012)
CZ (1) CZ293482B6 (en, 2012)
DE (2) DE19817264A1 (en, 2012)
DK (1) DK1080086T3 (en, 2012)
ES (1) ES2183548T3 (en, 2012)
GT (1) GT199900056A (en, 2012)
HU (1) HUP0102372A3 (en, 2012)
ID (1) ID27263A (en, 2012)
IL (2) IL138584A0 (en, 2012)
MY (1) MY126527A (en, 2012)
NO (2) NO321985B1 (en, 2012)
NZ (1) NZ507569A (en, 2012)
PE (1) PE20000427A1 (en, 2012)
PL (1) PL193898B1 (en, 2012)
PT (1) PT1080086E (en, 2012)
RU (1) RU2245881C9 (en, 2012)
SI (1) SI1080086T1 (en, 2012)
SK (1) SK286407B6 (en, 2012)
SV (1) SV1999000047A (en, 2012)
TR (1) TR200003011T2 (en, 2012)
TW (1) TW548274B (en, 2012)
UA (1) UA63998C2 (en, 2012)
WO (1) WO1999054326A1 (en, 2012)
ZA (1) ZA200005136B (en, 2012)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058302A1 (de) * 1999-03-25 2000-10-05 Bayer Aktiengesellschaft Dihydropyrimidine und ihre verwendung zur behandlung von hepatitis b
AU5568400A (en) 1999-06-23 2001-01-09 Ajinomoto Co., Inc. Novel dihydropyrimidine derivatives
AU3009801A (en) * 1999-12-22 2001-07-03 Bayer Aktiengesellschaft Combinations of medicaments for treating viral diseases
DE10012823A1 (de) * 2000-03-16 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013125A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013126A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10125131A1 (de) * 2001-05-23 2002-12-05 Bayer Ag Verfahren zur Spaltung des Methyl 4-(2-chlor-4-fluorphenyl)-2-(3,5-difluor-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrmidincarboxylat-Racemats
US20040092735A1 (en) * 2002-11-08 2004-05-13 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefuroxime sodium
CN101104617B (zh) 2006-07-10 2010-06-23 北京摩力克科技有限公司 二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
CN101104604B (zh) 2006-07-10 2011-03-02 北京摩力克科技有限公司 光学纯二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
RU2452733C2 (ru) * 2007-04-27 2012-06-10 Пэдью Фарма Л.П. Антагонисты trpv1 и их применение
PT2159224E (pt) * 2007-06-18 2012-10-24 Sunshine Lake Pharma Co Ltd Tiazolil dihidropirimidinas substituídas com bromo-fenilo
CN101686938B (zh) 2007-07-12 2012-09-05 诺瓦提斯公司 包含替比夫定的口服药物溶液
US20130267517A1 (en) 2012-03-31 2013-10-10 Hoffmann-La Roche Inc. Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
RU2655914C9 (ru) 2012-08-24 2018-07-24 Саншайн Лейк Фарма Ко., Лтд. Соединения дигидропиримидина и их применение в фармацевтических препаратах
CN104603125A (zh) 2012-09-10 2015-05-06 弗·哈夫曼-拉罗切有限公司 用于治疗和预防乙型肝炎病毒感染的6-氨基酸杂芳基二氢嘧啶
CN103664899B (zh) * 2012-09-11 2017-06-16 广东东阳光药业有限公司 杂芳基取代的二氢嘧啶类化合物及其在药物中的应用
SG11201503475WA (en) * 2012-11-09 2015-05-28 Univ Indiana Res & Tech Corp Alternative uses for hbv assembly effectors
BR102014028162A2 (pt) * 2013-11-12 2015-09-08 Dow Agrosciences Llc processo para fluoração de compostos
WO2015074546A1 (en) 2013-11-19 2015-05-28 Sunshine Lake Pharma Co., Ltd. Dihydropyrimidine compounds and their application in pharmaceuticals
WO2015078391A1 (en) 2013-11-27 2015-06-04 Sunshine Lake Pharma Co., Ltd. Processes for preparing dihydropyrimidine derivatives and intermediates thereof
CN104945395B (zh) 2014-03-28 2018-01-23 广东东阳光药业有限公司 二氢嘧啶类化合物及其在药物中的应用
CN105153164B (zh) * 2014-05-30 2018-10-30 齐鲁制药有限公司 作为hbv抑制剂的二氢嘧啶并环衍生物
US9938301B2 (en) 2014-05-30 2018-04-10 Qilu Pharmaceutical Co., Ltd. Dihydropyrimido fused ring derivative as HBV inhibitor
EP3253751B1 (en) 2015-02-07 2020-12-09 Sunshine Lake Pharma Co., Ltd. Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals
EP3645516A4 (en) * 2017-06-27 2021-07-07 Janssen Pharmaceutica NV HETEROARYLDIHYDROPYRIMIDE DERIVATIVES AND METHODS OF TREATMENT OF HEPATITIS B INFECTIONS
US10759774B2 (en) 2017-09-28 2020-09-01 The Curators Of The University Of Missouri Inhibitors of hepatitis B virus targeting capsid assembly
CN111448199A (zh) 2017-11-02 2020-07-24 艾库里斯有限及两合公司 具有抗乙型肝炎病毒(hbv)活性的新的高活性的氨基-噻唑取代的吲哚-2-甲酰胺
BR112020008765A2 (pt) 2017-11-02 2020-10-20 Aicuris Gmbh & Co. Kg indol-2-carboxamidas pirazolo-piperidina substituídas altamente ativas inovadoras ativas contra o vírus da hepatite b (hbv)
AU2019266729A1 (en) * 2018-05-08 2021-03-11 Janssen Sciences Ireland Unlimited Company Dihydropyrimidine derivatives and uses thereof in the treatment of HBV infection or of HBV-induced diseases
US11053235B2 (en) 2018-08-09 2021-07-06 Janssen Sciences Ireland Unlimited Company Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases
UY38437A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (hbv)
UY38434A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv)
SG11202104132WA (en) * 2018-11-02 2021-05-28 Aicuris Gmbh & Co Kg Novel urea 6,7-dihydro-4h-thiazolo[5,4-c]pyridines active against the hepatitis b virus (hbv)
AR116947A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas-indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
AR116948A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (vhb)
UY38439A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Novedosas urea 6,7-dihidro-4h-pirazolo[4,3-c]piridinas activas contra el virus de la hepatitis b (vhb)
US20220048919A1 (en) 2018-12-20 2022-02-17 Janssen Phrmaceutica NV Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infections
AU2020267015A1 (en) 2019-04-30 2021-12-23 Aicuris Gmbh & Co. Kg Novel indole-2-carboxamides active against the hepatitis B virus (HBV)
EP3962913A1 (en) 2019-04-30 2022-03-09 AiCuris GmbH & Co. KG Novel indolizine-2-carboxamides active against the hepatitis b virus (hbv)
CU20210089A7 (es) 2019-04-30 2022-06-06 Aicuris Gmbh & Co Kg Compuestos derivados de fenil y piridil ureas activas contra el virus de la hepatitis b (vhb)
CU20210090A7 (es) 2019-04-30 2022-06-06 Aicuris Gmbh & Co Kg Compuestos derivados de oxalil piperazinas activos contra el virus de la hepatitis b (vhb)
WO2020255016A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130304C (en, 2012) * 1964-02-12
CH550189A (de) 1971-01-08 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren.
CH569043A5 (en, 2012) 1973-01-23 1975-11-14 Ciba Geigy Ag
US4371537A (en) * 1981-08-13 1983-02-01 The Dow Chemical Company Sulfur-substituted phenoxypyridines having antiviral activity
DE3234684A1 (de) 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS60185764A (ja) 1984-03-05 1985-09-21 Wako Pure Chem Ind Ltd ピリジン誘導体の新規な製造法
US4698340A (en) * 1984-07-19 1987-10-06 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives, processes for preparation thereof and composition containing the same
US4727073A (en) 1984-10-01 1988-02-23 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives and composition of the same
GB8906168D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
JP2001503762A (ja) * 1996-11-12 2001-03-21 ノバルティス アクチェンゲゼルシャフト 除草剤として有用なピラゾール誘導体
SE9702564D0 (sv) 1997-07-02 1997-07-02 Astra Ab New compounds

Also Published As

Publication number Publication date
ID27263A (id) 2001-03-22
CN1159311C (zh) 2004-07-28
ATE223401T1 (de) 2002-09-15
CN1305471A (zh) 2001-07-25
ZA200005136B (en) 2001-03-02
NO329020B1 (no) 2010-07-26
US20040167135A1 (en) 2004-08-26
BRPI9917862B8 (pt) 2021-05-25
DE59902573D1 (en) 2002-10-10
US20070117812A1 (en) 2007-05-24
GT199900056A (es) 2000-10-07
US7514565B2 (en) 2009-04-07
MY126527A (en) 2006-10-31
EP1080086B1 (de) 2002-09-04
CA2328780C (en) 2008-09-23
US6696451B1 (en) 2004-02-24
RU2245881C2 (ru) 2005-02-10
NO321985B1 (no) 2006-07-31
CZ20003871A3 (cs) 2001-01-17
UA63998C2 (uk) 2004-02-16
BRPI9917862A2 (en, 2012) 2010-12-07
WO1999054326A8 (de) 1999-12-29
ES2183548T3 (es) 2003-03-16
BG104812A (en) 2001-06-29
PT1080086E (pt) 2002-12-31
AU740318B2 (en) 2001-11-01
DE19817264A1 (de) 1999-10-21
BR9909730B1 (pt) 2012-09-04
JP2002512243A (ja) 2002-04-23
CU23049A3 (es) 2005-06-24
AR018187A1 (es) 2001-10-31
KR100636771B1 (ko) 2006-10-23
RU2245881C9 (ru) 2006-02-10
CZ293482B6 (cs) 2004-05-12
KR20010042788A (ko) 2001-05-25
NZ507569A (en) 2002-04-26
NO20005215D0 (no) 2000-10-17
PL193898B1 (pl) 2007-03-30
BR9909730A (pt) 2000-12-19
HUP0102372A3 (en) 2003-01-28
JP2010241837A (ja) 2010-10-28
BRPI9917862B1 (pt) 2013-05-07
WO1999054326A1 (de) 1999-10-28
PL343481A1 (en) 2001-08-27
NO20045259L (no) 2000-12-13
DK1080086T3 (da) 2002-12-23
SI1080086T1 (en) 2003-02-28
HK1039119A1 (en) 2002-04-12
EP1080086A1 (de) 2001-03-07
AU3813399A (en) 1999-11-08
BG64649B1 (bg) 2005-10-31
SV1999000047A (es) 2000-06-23
SK15652000A3 (sk) 2001-04-09
PE20000427A1 (es) 2000-06-25
JP4590097B2 (ja) 2010-12-01
TW548274B (en) 2003-08-21
JP5237332B2 (ja) 2013-07-17
NO20005215L (no) 2000-12-13
SK286407B6 (sk) 2008-09-05
CO5021127A1 (es) 2001-03-27
IL138584A0 (en) 2001-10-31
HUP0102372A2 (hu) 2001-12-28
IL138584A (en) 2006-09-05
CA2328780A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
TR200003011T2 (tr) Yeni dihidropirimidinler.
TR200102800T2 (tr) Yeni bileşikler.
DK1200418T3 (da) Nematodicide trifluorbutener
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
TR200101709T2 (tr) İltihabik hastalıkların tedavisinde yararlı olan bileşikler
TR200000197T2 (tr) Yeni bileşimler
GB9813540D0 (en) Chemical compounds
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
TR200100410T2 (tr) 2-(purin-9-il)-tetrahidrofuran-3,4-diol türevleri.
TR199901305T2 (xx) Calpain-�nleyicileri olarak ketonbenzamidler
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
PT1274687E (pt) Derivados de 1,2,3,4-tetra-hidroisoquinolina
GB0011203D0 (en) Chemical compounds
MXPA03002911A (es) Compuestos quimicos.
TR199900856T2 (xx) Bron�la ilgili terapi maddeleri olarak benzonaftiridinler
TR200000152T2 (tr) Yeni bileşikler.
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
ATE386525T1 (de) 3-substituierte 6,7- dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
DK1204659T3 (da) Serotonerge benzofuraner
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
SE9904128D0 (sv) Novel compounds